Billiontoone (NASDAQ:BLLN) CEO Sells 12,500 Shares

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 12,500 shares of the company’s stock in a transaction dated Thursday, July 9th. The stock was sold at an average price of $126.10, for a total value of $1,576,250.00. Following the transaction, the chief executive officer directly owned 12,500 shares of the company’s stock, valued at approximately $1,576,250. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, July 6th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $1,525,625.00.
• On Monday, July 6th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $3,203,812.50.
• On Monday, June 8th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $98.22, for a total value of $1,227,750.00.
• On Monday, June 8th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The shares were sold at an average price of $97.66, for a total transaction of $2,563,575.00.

Billiontoone Stock Down 2.8%

Billiontoone stock traded down $3.52 during mid-day trading on Monday, hitting $123.25. The company had a trading volume of 596,578 shares, compared to its average volume of 490,947. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $138.70. The business has a fifty day moving average of $100.50 and a 200 day moving average of $88.83. The stock has a market cap of $5.67 billion and a price-to-earnings ratio of 224.09.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. During the same quarter in the prior year, the firm posted ($0.39) EPS. The firm’s quarterly revenue was up 83.8% compared to the same quarter last year. On average, sell-side analysts expect that Billiontoone, Inc. will post 0.93 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Billiontoone

A number of hedge funds have recently modified their holdings of BLLN. Baillie Gifford & Co. purchased a new position in shares of Billiontoone during the fourth quarter worth about $103,786,000. Massachusetts Financial Services Co. MA purchased a new stake in Billiontoone during the 4th quarter valued at approximately $13,373,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Billiontoone during the 4th quarter worth approximately $1,348,000. UBS Group AG acquired a new stake in Billiontoone during the 4th quarter worth approximately $2,586,000. Finally, Wasatch Advisors LP purchased a new position in shares of Billiontoone in the 1st quarter valued at approximately $29,179,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. BTIG Research reduced their price target on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Guggenheim started coverage on Billiontoone in a report on Monday, June 29th. They set a “buy” rating and a $125.00 price objective on the stock. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Finally, JPMorgan Chase & Co. boosted their target price on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $126.00.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.